protein kinase C, delta

Nomenclature: protein kinase C, delta

Abbreviated Name: PKCδ

Family: Delta subfamily

Annotation status:  image of an orange circle Annotated and awaiting review. Please contact us if you can help with reviewing.  » Email us

Contents:

Gene and Protein Information
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - 676 3p21.31 PRKCD protein kinase C, delta
Mouse - 674 14 Prkcd protein kinase C, delta
Rat - 673 16p16 Prkcd protein kinase C, delta
Previous and Unofficial Names
Pkcd
nPKC-delta
protein kinase C delta type
PKC[d]
PKCdelta
D14Ertd420e
PKCδ
Database Links
BRENDA 2.7.11.13
Ensembl Gene ENSG00000163932 (Hs), ENSMUSG00000021948 (Mm), ENSRNOG00000016346 (Rn)
Entrez Gene 5580 (Hs), 18753 (Mm), 170538 (Rn)
ExplorEnz 2.7.11.13
GeneCards PRKCD (Hs)
GenitoUrinary Development Molecular Anatomy Project Prkcd (Mm)
HomoloGene 55963 (Hs)
Human Protein Reference Database 01501 (Hs)
InterPro Q05655 (Hs), P28867 (Mm), P09215 (Rn)
KEGG BRITE Hierarchy 2.7.11.13
KEGG Gene hsa:5580 (Hs), mmu:18753 (Mm), rno:170538 (Rn)
OMIM 176977 (Hs)
Orphanet Gene ORPHA332077 (Hs)
PhosphoSitePlus Q05655 (Hs), P28867 (Mm), P09215 (Rn)
RefSeq Nucleotide NM_006254 (Hs), NM_011103 (Mm), NM_133307 (Rn)
RefSeq Protein NP_006245 (Hs), NP_035233 (Mm), NP_579841 (Rn)
TreeFam PRKCD
UniGene Hs.155342 (Hs)
UniProtKB Q05655 (Hs), P28867 (Mm), P09215 (Rn)
Wikipedia protein kinase C, delta
Selected 3D Structures
Image of receptor 3D structure from RCSB PDB
Description:  Solution structure of the first Phorbol esters/diacylglycerol binding domain of human Protein kinase C, delta
PDB Id:  2YUU
Resolution:  0.0Å
Species:  Human
References: 
Enzyme Reaction
EC Number: 2.7.11.13
Activators
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
ingenol mebutate Hs Activation 9.42 pKi 7
pKi 9.42 (Ki 3.76x10-10 M) [7]
Inhibitors
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
ruboxistaurin Hs Inhibition 6.6 pIC50 6
pIC50 6.6 (IC50 2.5x10-7 M) [6]
enzastaurin Hs Inhibition 6.0 pIC50 4
pIC50 6.0 (IC50 1x10-6 M) [4]
DiscoveRx KINOMEscan® screen
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform.
http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan
Reference: 3,9
Key to terms and symbols Click column headers to sort
Target used in screen: PRKCD
Ligand Sp. Type Action Affinity Units
staurosporine Hs Inhibitor Inhibition 8.82 pKd
ruboxistaurin Hs Inhibitor Inhibition 8.44 pKd
enzastaurin Hs Inhibitor Inhibition 7.6 pKd
A-674563 Hs Inhibitor Inhibition 7.57 pKd
GSK690693 Hs Inhibitor Inhibition 7.27 pKd
lestaurtinib Hs Inhibitor Inhibition 6.62 pKd
midostaurin Hs Inhibitor Inhibition 6.49 pKd
alvocidib Hs Inhibitor Inhibition 6.23 pKd
bosutinib Hs Inhibitor Inhibition 5.8 pKd
tofacitinib Hs Inhibitor Inhibition 5.7 pKd
Displaying the top 10 most potent ligands  View all ligands in screen »
EMD Millipore KinaseProfilerTM screen/Reaction Biology Kinase HotspotSM screen
A screen profiling 158 kinase inhibitors (Calbiochem Protein Kinase Inhibitor Library I and II, catalogue numbers 539744 and 539745) for their inhibitory activity at 1µM and 10µM against 234 human recombinant kinases using the EMD Millipore KinaseProfilerTM service.

A screen profiling the inhibitory activity of 178 commercially available kinase inhibitors at 0.5µM against a panel of 300 recombinant protein kinases using the Reaction Biology Corporation Kinase HotspotSM platform.

http://www.millipore.com/techpublications/tech1/pf3036
http://www.reactionbiology.com/webapps/main/pages/kinase.aspx

Reference: 1,5
Key to terms and symbols Click column headers to sort
Target used in screen: PKCδ/PKCd
Ligand Sp. Type Action % Activity remaining at 0.5µM % Activity remaining at 1µM % Activity remaining at 10µM
Gö6983 Hs Inhibitor Inhibition 1.7 3.0 -1.0
GF109203X Hs Inhibitor Inhibition 4.7 2.0 -1.0
staurosporine Hs Inhibitor Inhibition 5.6 0.5 0.5
Ro-32-0432 Hs Inhibitor Inhibition 8.1
midostaurin Hs Inhibitor Inhibition 10.9 21.0 9.0
K-252a Hs Inhibitor Inhibition 12.6 18.0 3.0
SB 218078 Hs Inhibitor Inhibition 19.0 103.0 92.0
PKCbeta inhibitor Hs Inhibitor Inhibition 19.3 8.0 2.0
Cdk1/2 inhibitor III Hs Inhibitor Inhibition 22.2 10.0 9.0
Rho kinase inhibitor IV Hs Inhibitor Inhibition 22.4 7.0 3.0
Displaying the top 10 most potent ligands  View all ligands in screen »
Clinically-Relevant Mutations and Pathophysiology
Disease:  Immunodeficiency, common variable, 9
OMIM:  615559
Orphanet:  1572
References: 
Mutations not determined
Disease:  Autoimmune lymphoproliferative syndrome
Orphanet:  3261
References:  8
Click column headers to sort
Type Species Molecular location Description Reference
Deletion Human p.R614W This deleterious homozygous mutation results in loss of function of the protein 8
Disease:  Autosomal recessive systemic lupus erythematosus
Orphanet:  300345
References:  2
Click column headers to sort
Type Species Molecular location Description Reference
Missense Human G510S Nucleotide transition 1528G>A results in a glycine to serine amino acid substitution. 2

References

Show »

1. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat. Biotechnol., 29 (11): 1039-45. [PMID:22037377]

2. Belot A, Kasher PR, Trotter EW, Foray AP, Debaud AL, Rice GI, Szynkiewicz M, Zabot MT, Rouvet I, Bhaskar SS et al.. (2013) Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. Arthritis Rheum., 65 (8): 2161-71. [PMID:23666743]

3. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat. Biotechnol., 29 (11): 1046-51. [PMID:22037378]

4. Faul MM, Gillig JR, Jirousek MR, Ballas LM, Schotten T, Kahl A, Mohr M. (2003) Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCbeta. Bioorg. Med. Chem. Lett., 13 (11): 1857-9. [PMID:12749884]

5. Gao Y, Davies SP, Augustin M, Woodward A, Patel UA, Kovelman R, Harvey KJ. (2013) A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. Biochem. J., 451 (2): 313-28. [PMID:23398362]

6. Jirousek MR, Gillig JR, Gonzalez CM, Heath WF, McDonald JH, Neel DA, Rito CJ, Singh U, Stramm LE, Melikian-Badalian A et al.. (1996) (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta. J. Med. Chem., 39 (14): 2664-71. [PMID:8709095]

7. Kedei N, Lundberg DJ, Toth A, Welburn P, Garfield SH, Blumberg PM. (2004) Characterization of the interaction of ingenol 3-angelate with protein kinase C. Cancer Res., 64 (9): 3243-55. [PMID:15126366]

8. Kuehn HS, Niemela JE, Rangel-Santos A, Zhang M, Pittaluga S, Stoddard JL, Hussey AA, Evbuomwan MO, Priel DA, Kuhns DB et al.. (2013) Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans. Blood, 121 (16): 3117-25. [PMID:23430113]

9. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem. Biol., 17 (11): 1241-9. [PMID:21095574]

How to cite this page

Delta subfamily: protein kinase C, delta. Last modified on 22/05/2014. Accessed on 22/07/2014. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1485.